Neuroanatomical substrates involved in cannabinoid modulation of defensive responses

Journal of Psychopharmacology

Volumn 26, Issue 1, 2012, Pages 40-55

  Moreira, F A ^a   Aguiar, D C ^a   Resstel, L B ^b   Lisboa, S F ^b   Campos, A C ^b   Gomes, F V ^b   Guimaraes F S ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amygdala; anxiety; bed nucleus of the stria terminalis; cannabidiol; endocannabinoid; hippocampus; medial prefrontal cortex; periaqueductal gray

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CANNABIDIOL; CANNABINOID DERIVATIVE; CAPSAICIN; CAPSAZEPINE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DEXANABINOL; METHANANDAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; RIMONABANT; TETRAHYDROCANNABINOLIC ACID;

AMYGDALOID NUCLEUS; BRAIN FUNCTION; BRAIN NERVE CELL; CELL ACTIVITY; CHOLINERGIC TRANSMISSION; CONCENTRATION RESPONSE; DEFENSIVE BEHAVIOR; DRUG TARGETING; GABAERGIC TRANSMISSION; HUMAN; MEDIAL PREFRONTAL CORTEX; NEUROANATOMY; NEUROMODULATION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; STRESS; STRIA TERMINALIS; TRANQUILIZING ACTIVITY;

ANIMALS; BRAIN; CANNABINOIDS; DEFENSE MECHANISMS; HUMANS; NEUROANATOMY; SYNAPTIC TRANSMISSION;

EID: 84856436786     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111400651     Document Type: Review

References (245)

1. Abbruzzese M, Bellodi L, Ferri S, Scarone S. Frontal lobe dysfunction in schizophrenia and obsessive-compulsive disorder: a neuropsychological study. Brain Cogn. 1995 ; 27: 202-212
2. Adamec RE, Burton P, Shallow T, Budgell J. NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure-implications for anxiety associated with posttraumatic stress disorder. Physiol Behav. 1999 ; 65: 723-737 (Pubitemid 29094709)
3. Adolphs R, Tranel D, Damasio H, Damasio A. Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature. 1994 ; 372: 669-672
4. Aguiar DC, Guimarães FS. Blockade of NMDA receptors and nitric oxide synthesis in the dorsolateral periaqueductal gray attenuates behavioral and cellular responses of rats exposed to a live predator. J Neurosci Res. 2009 ; 87: 2418-2429
5. Aguiar DC, Terzian AL, Guimarães FS, Moreira FA. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. Psychopharmacology (Berl). 2009 ; 205: 217-225
6. Alonso R, Voutsinos B, Fournier M, Labie C, Steinberg R, Souilhac J, et al. Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function. Neuroscience. 1999 ; 91: 607-620 (Pubitemid 29193270)
7. Anagnostaras SG, Maren S, Fanselow MS. Temporally graded retrograde amnesia of contextual fear after hippocampal damage in rats: within-subjects examination. J Neurosci. 1999 ; 19: 1106-1114 (Pubitemid 29066171)
8. Arenos JD, Musty RE, Bucci DJ. Blockade of cannabinoid CB1 receptors alters contextual learning and memory. Eur J Pharmacol. 2006 ; 539: 177-183 (Pubitemid 43783526)
9. Arnold JC, Topple AN, Mallet PE, Hunt GE, McGregor IS. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Res. 2001 ; 921: 240-255 (Pubitemid 33096304)
10. Auclair N, Otani S, Soubrie P, Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol. 2000 ; 83: 3287-3293 (Pubitemid 30408863)
11. Azad SC, Eder M, Marsicano G, Lutz B, Zieglgansberger W, Rammes G. Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learn Mem. 2003 ; 10: 116-128 (Pubitemid 36418722)
12. Azad SC, Kurz J, Marsicano G, Lutz B, Zieglgansberger W, Rammes G. Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala. Learn Mem. 2008 ; 15: 143-152 (Pubitemid 351439144)
13. Baeg EH, Kim YB, Jang J, Kim HT, Mook-Jung I, Jung MW. Fast spiking and regular spiking neural correlates of fear conditioning in the medial prefrontal cortex of the rat. Cereb Cortex. 2001 ; 11: 441-451 (Pubitemid 32428070)
14. Bandler R, Keay KA, Floyd N, Price J. Central circuits mediating patterned autonomic activity during active vs. passive emotional coping. Brain Res Bull. 2000 ; 53: 95-104
15. Bannerman DM, Rawlins JN, McHugh SB, et al. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev. 2004 ; 28: 273-283 (Pubitemid 38844376)
16. Beck CH, Fibiger HC. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment. J Neurosci. 1995 ; 15: 709-720
17. Beijamini V, Guimarães FS. c-Fos expression increase in NADPH-diaphorase positive neurons after exposure to a live cat. Behav Brain Res. 2006 ; 170: 52-61
18. Bertoglio LJ, Joca SR, Guimarães FS. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav Brain Res. 2006 ; 175: 183-188 (Pubitemid 44691934)
19. Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010 ; 35: 764-774
20. Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ, et al. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem Biophys Res Commun. 1999 ; 256: 377-380 (Pubitemid 29298893)
21. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, et al. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol. 2001 ; 134: 845-852 (Pubitemid 33016156)
22. Bitencourt RM, Pamplona FA, Takahash RN. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur Neuropsychopharmacol. 2008 ; 18: 849-859
23. Blanchard DC, Blanchard RJ. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J Comp Physiol Psychol. 1972 ; 81: 281-290
24. Blanchard DC, Blanchard RJ, Carobrez AP, Veniegas R, Rodgers RJ, Shepherd JK. MK-801 produces a reduction in anxiety-related antipredator defensiveness in male and female rats and a gender-dependent increase in locomotor behavior. Psychopharmacology (Berl). 1992 ; 108: 352-362
25. Bortolato M, Campolongo P, Mangieri RA, Scattoni ML, Frau R, Trezza V, et al. Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology. 2006 ; 31: 2652-2659 (Pubitemid 44764162)
26. Boshuisen ML, Ter Horst GJ, Paans AM, Reinders AA, den Boer JA. rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest. Biol Psychiatry. 2002 ; 52: 126-135 (Pubitemid 34756558)
27. Brett R, MacKenzie F, Pratt J. Delta 9-tetrahydrocannabinol-induced alterations in limbic system glucose use in the rat. Neuroreport. 2001 ; 12: 3573-3577 (Pubitemid 33065501)
28. Bucherelli C, Baldi E, Mariottini C, Passani MB, Blandina P. Aversive memory reactivation engages in the amygdala only some neurotransmitters involved in consolidation. Learn Mem. 2006 ; 13: 426-430 (Pubitemid 44157467)
29. Campeau S, Akil H, Watson SJ. Lesions of the medial geniculate nuclei specifically block corticosterone release and induction of c-fos mRNA in the forebrain associated with audiogenic stress in rats. J Neurosci. 1997a ; 17: 5979-5992 (Pubitemid 27310511)
30. Campeau S, Falls WA, Cullinan WE, Helmreich DL, Davis M, Watson SJ. Elicitation and reduction of fear: behavioural and neuroendocrine indices and brain induction of the immediate-early gene c-fos. Neuroscience. 1997b ; 78: 1087-1104 (Pubitemid 27223713)
31. Campolongo P, Roozendaal B, Trezza V, Hauer D, Schelling G, McGaugh JL, et al. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci U S A. 2009 ; 106: 4888-4893
32. Campos AC, Guimarães FS. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berl). 2008 ; 199: 223-230
33. Campos AC, Guimarães FS. Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry. 2009 ; 33: 1517-1521
34. Campos AC, Ferreira FR, Guimarães FS, Lemos JI. Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience. Neuroscience. 2010 ; 167: 238-246
35. Cannich A, Wotjak CT, Kamprath K, Hermann H, Lutz B, Marsicano G. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice. Learn Mem. 2004 ; 11: 625-632 (Pubitemid 39299714)
36. Cannistraro PA, Rauch SL. Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. Psychopharmacol Bull. 2003 ; 37: 8-25
37. Canteras NS, Goto M. Fos-like immunoreactivity in the periaqueductal gray of rats exposed to a natural predator. Neuroreport. 1999 ; 10: 413-418 (Pubitemid 29104823)
38. Carobrez AP. Glutamatergic neurotransmission as molecular target in anxiety. Rev Bras Psiquiatr. 2003 ; 25 (Suppl 2). 52-58
39. Carrive P. The periaqueductal gray and defensive behavior: functional representation and neuronal organization. Behav Brain Res. 1993 ; 58: 27-47 (Pubitemid 24024043)
40. Casada JH, Dafny N. Restraint and stimulation of bed nucleus of the stria terminalis produce similar stress-like behaviors. Brain Res Bull. 1991 ; 27: 207-212
41. Casarotto PC, Gomes FV, Resstel LB, Guimarães FS. Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors. Behav Pharmacol. 2010 ; 21: 353-358
42. Chhatwal JP, Davis M, Maguschak KA, Ressler KJ. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology. 2005 ; 30: 516-524 (Pubitemid 40271154)
43. Conde F, Maire-Lepoivre E, Audinat E, Crepel F. Afferent connections of the medial frontal cortex of the rat. II. Cortical and subcortical afferents. J Comp Neurol. 1995 ; 352: 567-593
44. Conrad CD, LeDoux JE, Magarinos AM, McEwen BS. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci. 1999 ; 113: 902-913 (Pubitemid 30130866)
45. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty acid amides. Nature. 1996 ; 384: 83-87 (Pubitemid 26374593)
46. Crestani CC, Alves FH, Tavares RF, Correa FM. Role of the bed nucleus of the stria terminalis in the cardiovascular responses to acute restraint stress in rats. Stress. 2009 ; 12: 268-278
47. Crippa JA, Zuardi AW, Garrido GE, Wichert-Ana L, Guarnieri R, Ferrari L, et al. Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology. 2004 ; 29: 417-426 (Pubitemid 38175159)
48. Cullinan WE, Herman JP, Battaglia DF, Akil H, Watson SJ. Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience. 1995 ; 64: 477-505
49. Dalley JW, Cardinal RN, Robbins TW. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev. 2004 ; 28: 771-784 (Pubitemid 39535871)
50. Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology. 2010 ; 35: 105-135
51. De Chiara V, Angelucci F, Rossi S, Musella A, Cavasinni F, Cantarella C, et al. Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. J Neurosci. 2010 ; 30: 8127-8137
52. de Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005 ; 6: 463-475 (Pubitemid 40769171)
53. Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988 ; 34: 605-613 (Pubitemid 19007296)
54. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992 ; 258: 1946-1949 (Pubitemid 23026736)
55. Di Marzo V, Bisogno T, De Petrocellis L. Anandamide: some like it hot. Trends Pharmacol Sci. 2001 ; 22: 346-349 (Pubitemid 32592472)
56. Di Marzo V, Maccarrone M. FAAH and anandamide: is 2-AG really the odd one out?. Trends Pharmacol Sci. 2008 ; 29: 229-233
57. Di Marzo V, Berrendero F, Bisogno T, Gonzalez S, Cavaliere P, Romero J, et al. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta 9-tetrahydrocannabinol- tolerant rats. J Neurochem. 2000 ; 74: 1627-1635 (Pubitemid 30163985)
58. Dias R, Aggleton JP. Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching- and matching-to-place in the T-maze in the rat: differential involvement of the prelimbic-infralimbic and anterior cingulate cortices in providing behavioural flexibility. Eur J Neurosci. 2000 ; 12: 4457-4466 (Pubitemid 32037854)
59. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A. 2002 ; 99: 10819-10824
60. Dong HW, Petrovich GD, Swanson LW. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev. 2001a ; 38: 192-246 (Pubitemid 34066502)
61. Dong HW, Petrovich GD, Watts AG, Swanson LW. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J Comp Neurol. 2001b ; 436: 430-455 (Pubitemid 32623063)
62. Duncan GE, Knapp DJ, Breese GR. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res. 1996 ; 713: 79-91 (Pubitemid 26114832)
63. Dunn JD. Plasma corticosterone responses to electrical stimulation of the bed nucleus of the stria terminalis. Brain Res. 1987 ; 407: 327-331 (Pubitemid 17085791)
64. Dunn JD, Williams TJ. Cardiovascular responses to electrical stimulation of the bed nucleus of the stria terminalis. J Comp Neurol. 1995 ; 352: 227-234
65. Egerton A, Pratt JA, Brett R. Differential dose effects of delta-9-tetrahydrocannabinol on behaviour and gene expression. Behav Pharmacol. 2001 ; 12: s13
66. Egertova M, Cravatt BF, Elphick MR. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience. 2003 ; 119: 481-496 (Pubitemid 36588826)
67. Fanselow MS, Helmstetter FJ. Conditional analgesia, defensive freezing, and benzodiazepines. Behav Neurosci. 1988 ; 102: 233-243
68. Fendt M, Fanselow MS. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev. 1999 ; 23: 743-760 (Pubitemid 29282023)
69. Finn DP, Jhaveri MD, Beckett SR, Roe CH, Kendall DA, Marsden CA, et al. Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology. 2003 ; 45: 594-604 (Pubitemid 36980816)
70. Finn DP, Beckett SR, Richardson D, Kendall DA, Marsden CA, Chapman V. Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors. Eur J Neurosci. 2004a ; 20: 848-852 (Pubitemid 39036946)
71. Finn DP, Jhaveri MD, Beckett SR, Kendall DA, Marsden CA, Chapman V. Cannabinoids modulate ultrasound-induced aversive responses in rats. Psychopharmacology (Berl). 2004b ; 172: 41-51 (Pubitemid 38299749)
72. Freedland CS, Whitlow CT, Miller MD, Porrino LJ. Dose-dependent effects of Delta 9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat. Synapse. 2002 ; 45: 134-142 (Pubitemid 34742949)
73. Frysztak RJ, Neafsey EJ. The effect of medial frontal cortex lesions on respiration, "freezing," and ultrasonic vocalizations during conditioned emotional responses in rats. Cereb Cortex. 1991 ; 1: 418-425
74. Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R, et al. Distinct effects of delta 9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry. 2009 ; 66: 95-105
75. Galeno TM, Van Hoesen GW, Brody MJ. Central amygdaloid nucleus lesion attenuates exaggerated hemodynamic responses to noise stress in the spontaneously hypertensive rat. Brain Res. 1984 ; 291: 249-259 (Pubitemid 14220197)
76. Ganon-Elazar E, Akirav I. Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J Neurosci. 2009 ; 29: 11078-11088
77. Gentile CG, Jarrell TW, Teich A, McCabe PM, Schneiderman N. The role of amygdaloid central nucleus in the retention of differential Pavlovian conditioning of bradycardia in rabbits. Behav Brain Res. 1986 ; 20: 263-273 (Pubitemid 16079800)
78. Glass M, Dragunow M, Faull RL. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience. 1997 ; 77: 299-318 (Pubitemid 27079604)
79. 1A receptors. J Psychopharmacol. 2011 ; 00: 00-00
80. Graeff FG. Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals. Braz J Med Biol Res. 1994 ; 27: 811-829
81. Gray JA, McNaughton N The Neuropsychology of Anxiety. An Enquiry into the Functions of the Septo-Hippocampal System. Oxford: Oxford University Press ; 2000 :
82. Grueter BA, Gosnell HB, Olsen CM, Schramm-Sapyta NL, Nekrasova T, Landreth GE, et al. Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration. J Neurosci. 2006 ; 26: 3210-3219
83. Guimarães FS, Chiaretti TM, Graeff FG, Zuardi AW. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berl). 1990 ; 100: 558-559 (Pubitemid 20102368)
84. Guimarães FS, de Aguiar JC, Mechoulam R, Breuer A. Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze. Gen Pharmacol. 1994 ; 25: 161-164 (Pubitemid 24055428)
85. Guimarães FS, Beijamini V, Moreira FA, Aguiar DC, de Lucca AC. Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev. 2005 ; 29: 1313-1322 (Pubitemid 41446902)
86. Hájos N, Freund TF. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem Phys Lipids. 2002 ; 121: 73-82 (Pubitemid 36044544)
87. Haller J, Barna I, Barsvari B, Gyimesi Pelczer K, Yasar S, Panlilio LV, et al. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology (Berl). 2009 ; 204: 607-616
88. Haller J, Mátyás F, Soproni K, Varga B, Barsy B, Németh B, et al. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission. Eur J Neurosci. 2007 ; 25: 2445-2456 (Pubitemid 46625912)
89. Haller J, Varga B, Ledent C, Barna I, et al. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci. 2004 ; 19: 1906-1912 (Pubitemid 38482578)
90. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A. 1990 ; 87: 1932-1936
91. Herkenham M. Characterization and localization of cannabinoid receptors in brain: an in vitro technique using slide-mounted tissue sections. NIDA Res Monogr. 1991 ; 112: 129-145 (Pubitemid 23078451)
92. Herkenham M. Cannabinoid receptor localization in brain: relationship to motor and reward systems. Ann N Y Acad Sci. 1992 ; 654: 19-32
93. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci. 1991 ; 11: 563-583
94. Hill MN, Gorzalka BB. Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure. Psychoneuroendocrinology. 2006 ; 31: 526-536 (Pubitemid 43375954)
95. Hill MN, Karatsoreos IN, Hillard CJ, McEwen BS. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology. 2010 ; 35: 1333-1338
96. Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ, et al. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology. 2009 ; 34: 2733-2745
97. Hill MN, Patel S, Carrier EJ, Rademacher DJ, et al. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology. 2005 ; 30: 508-515 (Pubitemid 40271153)
98. Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, et al. An endocannabinoid mechanism for stress-induced analgesia. Nature. 2005 ; 435: 1108-1112 (Pubitemid 40910518)
99. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002 ; 54: 161-202 (Pubitemid 34575709)
100. Iwata J, LeDoux JE, Meeley MP, Arneric S, Reis DJ. Intrinsic neurons in the amygdaloid field projected to by the medial geniculate body mediate emotional responses conditioned to acoustic stimuli. Brain Res. 1986 ; 383: 195-214 (Pubitemid 17179977)
101. Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009 ; 30: 515-527
102. Jacob W, Yassouridis A, Marsicano G, Monory K, Lutz B, Wotjak CT. Endocannabinoids render exploratory behaviour largely independent of the test aversiveness: role of glutamatergic transmission. Genes Brain Behav. 2009 ; 8: 685-698
103. Jardim MC, Guimarães FS. Role of glutamate ionotropic receptors in the dorsomedial hypothalamic nucleus on anxiety and locomotor behavior. Pharmacol Biochem Behav. 2004 ; 79: 541-546 (Pubitemid 39576172)
104. Jardim MC, Aguiar DC, Moreira FA, Guimarães FS. Role of glutamate ionotropic and benzodiazepine receptors in the ventromedial hypothalamic nucleus on anxiety. Pharmacol Biochem Behav. 2005 ; 82: 182-189 (Pubitemid 41423502)
105. Javanmard M, Shlik J, Kennedy SH, Vaccarino FJ, Houle S, Bradwejn J. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol Psychiatry. 1999 ; 45: 872-882 (Pubitemid 29185478)
106. Jay TM, Witter MP. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris leucoagglutinin. J Comp Neurol. 1991 ; 313: 574-586
107. Jennings EA, Vaughan CW, Christie MJ. Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro. J Physiol. 2001 ; 534: 805-812 (Pubitemid 32700877)
108. Jiang W, Zhang Y, Xiao L, Van Cleemput J, Ji SP, Bai G, et al. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest. 2005 ; 115: 3104-3116 (Pubitemid 41567575)
109. 2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners. J Biol Chem. 2007 ; 282: 3614-3623 (Pubitemid 47084458)
110. Jinks AL, McGregor IS. Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. Brain Res. 1997 ; 772: 181-190 (Pubitemid 27501699)
111. Kamprath K, Plendl W, Marsicano G, Deussing JM, Wurst W, Lutz B, et al. Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling. Genes Brain Behav. 2009 ; 8: 203-211
112. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A, et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med. 2003 ; 9: 76-81 (Pubitemid 36098263)
113. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, et al. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci. 2001 ; 21: 9506-9518 (Pubitemid 33096895)
114. Katona I, Freund TF. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med. 2008 ; 14: 923-930
115. Kim JJ, Fanselow MS. Modality-specific retrograde amnesia of fear. Science. 1992 ; 256: 675-677
116. Krettek JE, Price JL. Projections from the amygdaloid complex to the cerebral cortex and thalamus in the rat and cat. J Comp Neurol. 1977 ; 172: 687-722 (Pubitemid 8059157)
117. Lafenêtre P, Chaouloff F, Marsicano G. The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. Pharmacol Res. 2007 ; 56: 367-381 (Pubitemid 350026395)
118. Laviolette SR, Lipski WJ, Grace AA. A subpopulation of neurons in the medial prefrontal cortex encodes emotional learning with burst and frequency codes through a dopamine D4 receptor-dependent basolateral amygdala input. J Neurosci. 2005 ; 25: 6066-6075 (Pubitemid 40923473)
119. LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci. 2000 ; 23: 155-184
120. LeDoux JE, Cicchetti P, Xagoraris A, Romanski LM. The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J Neurosci. 1990 ; 10: 1062-1069
121. LeDoux JE, Iwata J, Cicchetti P, Reis DJ. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci. 1988 ; 8: 2517-2529
122. Lemos JI, Resstel LB, Guimarães FS. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. Behav Brain Res. 2010 ; 207: 105-111
123. Li Q, Yan H, Wilson WA, Swartzwelder HS. Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells. Brain Res. 2010 ; 1342: 127-137
124. Lin HC, Mao SC, Gean PW. Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle. Learn Mem. 2006 ; 13: 316-321
125. Lisboa SF, Reis DG, Lopes da Silva A, Corrêa FMA, Guimarães FG, Resstel LB. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. Int J Neuropsychopharmacol. 2010 ; 13: 1163-1173
126. Lisboa SF, Resstel LB, Aguiar DC, Guimarães FS. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. Eur J Pharmacol. 2008 ; 593: 73-78
127. Ludányi A, Eross L, Czirják S, Vajda J, Halász P, Watanabe M, et al. Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J Neurosci. 2008 ; 28: 2976-2990 (Pubitemid 351442292)
128. Luiten PG, Koolhaas JM, de Boer S, Koopmans SJ. The cortico-medial amygdala in the central nervous system organization of agonistic behavior. Brain Res. 1985 ; 332: 283-297 (Pubitemid 15107999)
129. Lundqvist T, Jonsson S, Warkentin S. Frontal lobe dysfunction in long-term cannabis users. Neurotoxicol Teratol. 2001 ; 23: 437-443 (Pubitemid 33044560)
130. Lutz B. Endocannabinoid signals in the control of emotion. Curr Opin Pharmacol. 2009 ; 9: 46-52
131. Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A, et al. Anandamide inhibits metabolism and physiological actions of 2- arachidonoylglycerol in the striatum. Nat Neurosci. 2008 ; 11: 152-159 (Pubitemid 351170502)
132. McDonald AJ, Mascagni F. Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons. Neuroscience. 2001 ; 107: 641-652 (Pubitemid 33097500)
133. McGregor IS, Arnold JC, Weber MF, Topple AN, Hunt GE. A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. Brain Res. 1998 ; 802: 19-26 (Pubitemid 28392153)
134. McGregor IS, Hargreaves GA, Apfelbach R, Hunt GE. Neural correlates of cat odor-induced anxiety in rats: region-specific effects of the benzodiazepine midazolam. J Neurosci. 2004 ; 24: 4134-4144 (Pubitemid 38620788)
135. McNaughton N, Corr PJ. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci Biobehav Rev. 2004 ; 28: 285-305 (Pubitemid 38844377)
136. Mailleux P, Vanderhaeghen JJ. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience. 1992 ; 48: 655-668
137. 1A receptor activation on the anxiogenic effects induced by isolation in the elevated plus-maze test. Physiol Behav. 1993 ; 54: 753-758 (Pubitemid 23275760)
138. Malkani S, Rosen JB. Induction of NGFI-B mRNA following contextual fear conditioning and its blockade by diazepam. Brain Res Mol Brain Res. 2000 ; 80: 153-165
139. Maren S, Fanselow MS. Electrolytic lesions of the fimbria/fornix, dorsal hippocampus, or entorhinal cortex produce anterograde deficits in contextual fear conditioning in rats. Neurobiol Learn Mem. 1997 ; 67: 142-149 (Pubitemid 27424468)
140. Maren S, Aharonov G, Fanselow MS. Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav Brain Res. 1997 ; 88: 261-274 (Pubitemid 27496322)
141. Margulies JE, Hammer RP. Delta 9-tetrahydrocannabinol alters cerebral metabolism in a biphasic, dose-dependent manner in rat brain. Eur J Pharmacol. 1991 ; 202: 373-378
142. Marsch R, Foeller E, Rammes G, Bunck M, Kossl M, Holsboer F, et al. Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J Neurosci. 2007 ; 27: 832-839 (Pubitemid 46174502)
143. Marsicano G, Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci. 1999 ; 11: 4213-4225 (Pubitemid 30009252)
144. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 2002 ; 418: 530-534 (Pubitemid 34851398)
145. Mato S, Pazos A. Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain. Neuropharmacology. 2004 ; 46: 716-726 (Pubitemid 38292976)
146. Matsuda LA, Bonner TI, Lolait SJ. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol. 1993 ; 327: 535-550 (Pubitemid 23033649)
147. Mechoulam R. Marihuana chemistry. Science. 1970 ; 168: 1159-1166
148. Mikics E, Dombi T, Barsvari B, Varga B, Ledent C, Freund TF, et al. The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice. Behav Pharmacol. 2006 ; 17: 223-230
149. Milad MR, Rauch SL. The role of the orbitofrontal cortex in anxiety disorders. Ann NY Acad Sci. 2007 ; 1121: 546-561
150. Mobbs D, Marchant JL, Hassabis D, Seymour B, Tan G, Gray M, et al. From threat to fear: the neural organization of defensive fear systems in humans. J Neurosci. 2009 ; 29: 12236-12243
151. Monory K, Blaudzun H, Massa F, Kaiser N, Lemberger T, Schütz G, et al. Genetic dissection of behavioural and autonomic effects of delta(9)-tetrahydrocannabinol in mice. PLoS Biol. 2007 ; 5: e269
152. Moreira FA, Guimarães FS. Lack of effects of clomipramine on Fos and NADPH-diaphorase double-staining in the periaqueductal gray after exposure to an innate fear stimulus. Physiol Behav. 2008 ; 94: 316-321 (Pubitemid 351680281)
153. Moreira FA, Lutz B. The endocannabinoid system: emotion, learning and addiction. Addict Biol. 2008 ; 13: 196-212 (Pubitemid 351698889)
154. Moreira FA, Aguiar DC, Guimarães FS. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Prog Neuropsychopharmacol Biol Psychiatry. 2006 ; 30: 1466-1471 (Pubitemid 44634958)
155. Moreira FA, Aguiar DC, Guimarães FS. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray. Neuropharmacology. 2007 ; 52: 958-965 (Pubitemid 46227483)
156. Moreira FA, Aguiar DC, Campos AC, Lisboa SF, Terzian AL, Resstel LB, et al. Antiaversive effects of cannabinoids: is the periaqueductal gray involved?. Neural Plast. 2009a ; 2009: 1-11
157. Moreira FA, Grieb M, Lutz B. Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best Pract Res Clin Endocrinol Metab. 2009b ; 23: 133-144
158. Moreira FA, Kaiser N, Monory K, Lutz B. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid- degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology. 2008 ; 54: 141-150 (Pubitemid 350299416)
159. Morgane PJ, Galler JR, Mokler DJ. A review of systems and networks of the limbic forebrain/limbic midbrain. Prog Neurobiol. 2005 ; 75: 143-160 (Pubitemid 40387416)
160. Morris JS, Frith CD, Perrett DI, Rowland D, Young AW, Calder AJ, et al. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature. 1996 ; 383: 812-815 (Pubitemid 26372662)
161. Morrow BA, Elsworth JD, Lee EJ, Roth RH. Divergent effects of putative anxiolytics on stress-induced fos expression in the mesoprefrontal system of the rat. Synapse. 2000 ; 36: 143-154 (Pubitemid 30196690)
162. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993 ; 365: 61-65 (Pubitemid 23305569)
163. Nagahara AH, Handa RJ. Age-related changes in c-fos mRNA induction after open-field exposure in the rat brain. Neurobiol Aging. 1997 ; 18: 45-55 (Pubitemid 27062186)
164. Nakazi M, Bauer U, Nickel T, Kathmann M, Schlicker E. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Naunyn Schmiedebergs Arch Pharmacol. 2000 ; 361: 19-24 (Pubitemid 30064649)
165. Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MR, et al. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport. 1997 ; 8: 491-496 (Pubitemid 27180108)
166. Nejo P, Lisboa SF, Guimarães FS, Resstel LBM. Facilitation of endocannabinoid-mediated neurotransmission in the dorsal hippocampus induces anxiolytic effects in rats submitted to the Vogel conflict test. Behav Pharmacol. 2009 ; 20: S53
167. O'Leary DS, Block RI, Flaum M, Schultz SK, Boles Ponto LL, Watkins GL, et al. Acute marijuana effects on rCBF and cognition: a PET study. Neuroreport. 2000 ; 11: 3835-3841
168. O'Leary DS, Block RI, Koeppel JA, Flaum M, Schultz SK, Andreasen NC, et al. Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology. 2002 ; 26: 802-816 (Pubitemid 34455033)
169. Onaivi ES, Chakrabarti A, Gwebu ET, Chaudhuri G. Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice. Behav Brain Res. 1995 ; 72: 115-125
170. Palazzos E, de Novellis V, Marabese I, Rossi F, Maione S. Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing. Curr Neuropharmacol. 2006 ; 4: 225-231
171. Pamplona FA, Takahashi RN. WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neurosci Lett. 2006 ; 397: 88-92 (Pubitemid 43340465)
172. Patel NA, Moldow RL, Patel JA, Wu G, Chang SL. Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. Brain Res. 1998 ; 797: 225-233 (Pubitemid 28332735)
173. Patel S, Cravatt BF, Hillard CJ. Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala. Neuropsychopharmacology. 2005a ; 30: 497-507 (Pubitemid 40271152)
174. Patel S, Roelke CT, Rademacher DJ, Hillard CJ. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur J Neurosci. 2005b ; 21: 1057-1069 (Pubitemid 40461057)
175. Pertwee RG. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol. 2008 ; 13: 147-159 (Pubitemid 351698890)
176. Petrovich GD, Canteras NS, Swanson LW. Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems. Brain Res Brain Res Rev. 2001 ; 38: 247-289 (Pubitemid 34070636)
177. Phan KL, Angstadt M, Golden J, Onyewuenyi I, Popovska A, de Wit H. Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci. 2008 ; 28: 2313-2319 (Pubitemid 351348194)
178. Phillips RG, LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci. 1992 ; 106: 274-285
179. Pitkanen A, Savander V, LeDoux JE. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci. 1997 ; 20: 517-523 (Pubitemid 27459657)
180. Puente N, Elezgarai I, Lafourcade M, Reguero L, Marsicano G, Georges F, et al. Localization and function of the cannabinoid CB1 receptor in the anterolateral bed nucleus of the stria terminalis. PLoS One. 2010 ; 5: e8869
181. Quirk GJ, Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology. 2008 ; 33: 56-72 (Pubitemid 350191313)
182. Rademacher DJ, Meier SE, Shi L, Ho WS, Jarrahian A, Hillard CJ. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology. 2008 ; 54: 108-116 (Pubitemid 350299407)
183. Reich CG, Mohammadi MH, Alger BE. Endocannabinoid modulation of fear responses: learning and state-dependent performance effects. J Psychopharmacol. 2008 ; 22: 769-777
184. Reich CG, Taylor ME, McCarthy MM. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behav Brain Res. 2009 ; 203: 264-269
185. Resstel LB, Correa FM. Involvement of the medial prefrontal cortex in central cardiovascular modulation in the rat. Auton Neurosci. 2006 ; 126-127: 130-138 (Pubitemid 43816931)
186. Resstel LB, Alves FH, Reis DG, Crestani CC, Correa FM, Guimarães FS. Anxiolytic-like effects induced by acute reversible inactivation of the bed nucleus of stria terminalis. Neuroscience. 2008a ; 154: 869-876
187. Resstel LB, Correa FM, Guimarães FS. The expression of contextual fear conditioning involves activation of an NMDA receptor-nitric oxide pathway in the medial prefrontal cortex. Cereb Cortex. 2008b ; 18: 2027-2035
188. Resstel LB, Joca SR, Guimarães FG, Correa FM. Involvement of medial prefrontal cortex neurons in behavioral and cardiovascular responses to contextual fear conditioning. Neuroscience. 2006a ; 143: 377-385 (Pubitemid 44716591)
189. Resstel LB, Joca SR, Moreira FA, Correa FM, Guimarães FS. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav Brain Res. 2006b ; 172: 294-298 (Pubitemid 44148829)
190. Resstel LB, Lisboa SF, Aguiar DC, Correa FM, Guimarães FS. Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats. Psychopharmacology (Berl). 2008c ; 198: 405-411
191. Resstel LB, Moreira FA, Guimarães FS. Endocannabinoid system and fear conditioning. Vitam Horm. 2009 ; 81: 417-429
192. Resstel LB, Souza RF, Guimarães FS. Anxiolytic-like effects induced by medial prefrontal cortex inhibition in rats submitted to the Vogel conflict test. Physiol Behav. 2008d ; 93: 200-205
193. Roberto M, Cruz M, Bajo M, Siggins GR, Parsons LH, Schweitzer P. The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala. Neuropsychopharmacology. 2010 ; 5: 1962-1972
194. Roche M, O'Connor E, Diskin C, Finn DP. The effect of CB(1) receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats. Eur J Neurosci. 2007 ; 26: 2643-2653 (Pubitemid 350050435)
195. Roohbakhsh A, Keshavarz S, Hasanein P, Rezvani ME, Moghaddam AH. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours. Basic Clin Pharmacol Toxicol. 2009 ; 105: 333-338
196. Roohbakhsh A, Moghaddam AH, Massoudi R, Zarrindast MR. Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety-like behaviours in rats using the elevated plus-maze test. Clin Exp Pharmacol Physiol. 2007 ; 34: 223-229 (Pubitemid 46148266)
197. Rosen JB. The neurobiology of conditioned and unconditioned fear: a neurobehavioral system analysis of the amygdala. Behav Cogn Neurosci Rev. 2004 ; 3: 23-41
198. Rubino T, Guidali C, Vigano D, Realini N, Valenti M, Massi P, et al. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Neuropharmacology. 2008a ; 54: 151-160 (Pubitemid 350299412)
199. Rubino T, Realini N, Castiglioni C, Guidali C, Vigano D, Marras E, et al. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb Cortex. 2008b ; 18: 1292-1301 (Pubitemid 351769783)
200. Rubino T, Sala M, Vigano D, Braida D, Castiglioni C, Limonta V, et al. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta 9-tetrahydrocannabinol in rats. Neuropsychopharmacology. 2007 ; 32: 2036-2045 (Pubitemid 47258523)
201. Sah P, Faber ES, Lopez De Armentia M, Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev. 2003 ; 83: 803-834 (Pubitemid 36828926)
202. Saito VM, Wotjak CT, Moreira FA. Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?. Rev Bras Psiquiatr. 2010 ; 32 (Suppl 1). S7 - S14
203. Sandford JJ, Argyropoulos SV, Nutt DJ. The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology. Pharmacol Ther. 2000 ; 88: 197-212 (Pubitemid 32406052)
204. Santos CJ, Stern CA, Bertoglio LJ. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus. Behav Pharmacol. 2008 ; 19: 357-360
205. Schafe GE, Bauer EP, Rosis S, Farb CR, Rodrigues SM, LeDoux JE. Memory consolidation of Pavlovian fear conditioning requires nitric oxide signaling in the lateral amygdala. Eur J Neurosci. 2005 ; 22: 201-211 (Pubitemid 41059986)
206. Schlicker E, Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci. 2001 ; 22: 565-572 (Pubitemid 33042646)
207. Scott SK, Young AW, Calder AJ, Hellawell DJ, Aggleton JP, Johnson M. Impaired auditory recognition of fear and anger following bilateral amygdala lesions. Nature. 1997 ; 385: 254-257 (Pubitemid 27043724)
208. Sesack SR, Deutch AY, Roth RH, Bunney BS. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol. 1989 ; 290: 213-242 (Pubitemid 20006320)
209. Shammah-Lagnado SJ, Beltramino CA, McDonald AJ, Miselis RR, Yang M, de Olmos J, et al. Supracapsular bed nucleus of the stria terminalis contains central and medial extended amygdala elements: evidence from anterograde and retrograde tracing experiments in the rat. J Comp Neurol. 2000 ; 422: 533-555 (Pubitemid 30368393)
210. Siegel A, Tassoni JP. Differential efferent projections from the ventral and dorsal hippocampus of the cat. Brain Behav Evol. 1971 ; 4: 185-200
211. Sink KS, Segovia KN, Sink J, Randall PA, Collins LE, Correa M, et al. Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142. Eur Neuropsychopharmacol. 2010 ; 20: 112-122
212. 1A receptors. Behav Brain Res. 2010 ; 213: 225-229
213. Sotres-Bayon F, Cain CK, LeDoux JE. Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex. Biol Psychiatry. 2006 ; 60: 329-336 (Pubitemid 44215846)
214. Steiner MA, Wanisch K, Monory K, Marsicano G, et al. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics J. 2008 ; 8: 196-208 (Pubitemid 351712644)
215. Sullivan RM, Gratton A. Behavioral effects of excitotoxic lesions of ventral medial prefrontal cortex in the rat are hemisphere-dependent. Brain Res. 2002 ; 927: 69-79 (Pubitemid 34114050)
216. Sullivan GM, Apergis J, Bush DE, Johnson LR, Hou M, Ledoux JE. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience. 2004 ; 128: 7-14 (Pubitemid 39140675)
217. Sutt S, Raud S, Areda T, Reimets A, Koks S, Vasar E. Cat odour-induced anxiety-a study of the involvement of the endocannabinoid system. Psychopharmacology (Berl). 2008 ; 198: 509-520 (Pubitemid 351754672)
218. Suzuki A, Josselyn SA, Frankland PW, Masushige S, Silva AJ, Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci. 2004 ; 24: 4787-4795 (Pubitemid 38668203)
219. Swanson LW, Petrovich GD. What is the amygdala?. Trends Neurosci. 1998 ; 21: 323-331 (Pubitemid 28341956)
220. Szabo B, Dorner L, Pfreundtner C, Norenberg W, Starke K. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience. 1998 ; 85: 395-403 (Pubitemid 28218661)
221. Takagishi M, Chiba T. Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study. Brain Res. 1991 ; 566: 26-39
222. Tanimura A, Yamazaki M, Hashimotodani Y, Uchigashima M, Kawata S, Abe M, et al. The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron. 2010 ; 65: 320-327
223. Terzian AL, Aguiar DC, Guimarães FS, Moreira FA. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray. Eur Neuropsychopharmacol. 2009 ; 19: 188-195
224. Thomas EA, Cravatt BF, Danielson PE, Gilula NB, Sutcliffe JG. Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. J Neurosci Res. 1997 ; 50: 1047-1052 (Pubitemid 28034660)
225. Toth A, Boczan J, Kedei N, Lizanecz E, Bagi Z, Papp Z, et al. Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res. 2005 ; 135: 162-168 (Pubitemid 40602409)
226. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. 1998a ; 83: 393-411 (Pubitemid 28062631)
227. Tsou K, Nogueron MI, Muthian S, Sanudo-Pena MC, Hillard CJ, Deutsch DG, et al. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Lett. 1998b ; 254: 137-140 (Pubitemid 28459400)
228. Valjent E, Mitchell JM, Besson MJ, Caboche J, Maldonado R. Behavioural and biochemical evidence for interactions between delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol. 2002 ; 135: 564-578 (Pubitemid 34151189)
229. Vaughan CW, Connor M, Bagley EE, Christie MJ. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol Pharmacol. 2000 ; 57: 288-295 (Pubitemid 30084505)
230. Vertes RP. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience. 2006 ; 142: 1-20 (Pubitemid 44353937)
231. Vianna DM, Allen C, Carrive P. Cardiovascular and behavioral responses to conditioned fear after medullary raphe neuronal blockade. Neuroscience. 2008 ; 153: 1344-1353
232. Viveros MP, Marco EM, File SE. Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav. 2005 ; 81: 331-342 (Pubitemid 40807131)
233. Viveros MP, Marco EM, Llorente R, Lopez-Gallardo M. Endocannabinoid system and synaptic plasticity: implications for emotional responses. Neural Plast. 2007 ; 2007: 52908
234. Walker JM, Huang SM, Strangman NM, Tsou K, Sanudo-Pena MC. Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci U S A. 1999 ; 96: 12198-12203 (Pubitemid 29502881)
235. Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol. 2003 ; 463: 199-216 (Pubitemid 36205081)
236. Whitlow CT, Freedland CS, Porrino LJ. Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat. Psychopharmacology (Berl). 2002 ; 161: 129-136 (Pubitemid 34492657)
237. Wilson RI, Kunos G, Nicoll RA. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron. 2001 ; 31: 453-462 (Pubitemid 32778563)
238. Wilson RI, Nicoll RA. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature. 2001 ; 410: 588-592 (Pubitemid 32267203)
239. Xing J, Li J. TRPV1 receptor mediates glutamatergic synaptic input to dorsolateral periaqueductal gray (dl-PAG) neurons. J Neurophysiol. 2007 ; 97: 503-511 (Pubitemid 46143373)
240. Zangen A, Solinas M, Ikemoto S, Goldberg SR, Wise RA. Two brain sites for cannabinoid reward. J Neurosci. 2006 ; 26: 4901-4907 (Pubitemid 44315331)
241. Zarrindast MR, Mahboobi S, Sadat-Shirazi MS, Ahmadi S. Anxiolytic-like effect induced by the cannabinoid CB1 agonist, arachydonoylcyclopropilamide (ACPA), in the rat amygdale is mediated through the D1 and D2 dopaminergic systems. J Psychopharmacol. 2010a ; 25: 131-140
242. Zarrindast MR, Nasehi M, Piri M, Bina P. Anxiety-like behavior induced by histaminergic agents can be prevented by cannabinoidergic WIN55,212-2 injected into the dorsal hippocampus in mice. Pharmacol Biochem Behav. 2010b ; 94: 387-396
243. Zarrindast MR, Sarahroodi S, Arzi A, Khodayar MJ, Taheri-Shalmani S, Rezayof A. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system. Behav Pharmacol. 2008 ; 19: 716-723
244. Zuardi AW, Cosme RA, Graeff FG, Guimarães FS. Effects of ipsapirone and cannabidiol on human experimental anxiety. J Psychopharmacol. 1993 ; 7: 82-88 (Pubitemid 23099702)
245. Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimarães FS. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res. 2006 ; 39: 421-429